GLUCOBAY

Glucobay Adverse Events Reported to the FDA Over Time

How are Glucobay adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Glucobay, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Glucobay is flagged as the suspect drug causing the adverse event.

Most Common Glucobay Adverse Events Reported to the FDA

What are the most common Glucobay adverse events reported to the FDA?

Hypoglycaemia	52 (4.79%)
Intestinal Obstruction	30 (2.76%)
Aspartate Aminotransferase Increase...	24 (2.21%)
Alanine Aminotransferase Increased	22 (2.03%)
Diarrhoea	21 (1.94%)
Hepatic Function Abnormal	20 (1.84%)
Urinary Retention	19 (1.75%)
Vomiting	17 (1.57%)
Abdominal Distension	16 (1.47%)
Malaise	16 (1.47%)
Liver Disorder	15 (1.38%)
	Show More
Abdominal Pain	14 (1.29%)
Pneumatosis Intestinalis	14 (1.29%)
Hypoglycaemic Coma	13 (1.2%)
Nausea	13 (1.2%)
Ileus	12 (1.11%)
Blood Creatine Phosphokinase Increa...	11 (1.01%)
Gamma-glutamyltransferase Increased	11 (1.01%)
Pyrexia	10 (.92%)
Blood Glucose Increased	9 (.83%)
Metabolic Acidosis	9 (.83%)
Palpitations	9 (.83%)
Somnolence	9 (.83%)
Angina Pectoris	8 (.74%)
Anorexia	8 (.74%)
Arrhythmia	8 (.74%)
Blood Creatinine Increased	8 (.74%)
Glycosylated Haemoglobin Increased	8 (.74%)
Headache	8 (.74%)
Renal Failure	8 (.74%)
Weight Decreased	8 (.74%)
Blood Potassium Increased	7 (.65%)
Chromaturia	7 (.65%)
Diabetes Mellitus Inadequate Contro...	7 (.65%)
Dizziness	7 (.65%)
Drug Interaction	7 (.65%)
Dyspnoea	7 (.65%)
Flatulence	7 (.65%)
Hepatic Enzyme Increased	7 (.65%)
Hepatic Failure	7 (.65%)
Loss Of Consciousness	7 (.65%)
Renal Failure Acute	7 (.65%)
Rhabdomyolysis	7 (.65%)
Asthenia	6 (.55%)
Feeling Abnormal	6 (.55%)
Inflammation	6 (.55%)
Liver Function Test Abnormal	6 (.55%)
Oedema	6 (.55%)
Anuria	5 (.46%)
Blood Lactate Dehydrogenase Increas...	5 (.46%)
Chest Discomfort	5 (.46%)
Depressed Level Of Consciousness	5 (.46%)
Depression	5 (.46%)
Gait Disturbance	5 (.46%)
Gastrointestinal Perforation	5 (.46%)
Hepatitis Acute	5 (.46%)
Hyperhidrosis	5 (.46%)
Hyperkalaemia	5 (.46%)
International Normalised Ratio Incr...	5 (.46%)
Urinary Tract Infection	5 (.46%)
Alopecia	4 (.37%)
Coagulation Test Abnormal	4 (.37%)
Coma	4 (.37%)
Constipation	4 (.37%)
Duodenal Ulcer	4 (.37%)
Dysarthria	4 (.37%)
Erectile Dysfunction	4 (.37%)
Hydronephrosis	4 (.37%)
Hypoaesthesia	4 (.37%)
Jaundice	4 (.37%)
Myocardial Infarction	4 (.37%)
Oliguria	4 (.37%)
Prothrombin Time Prolonged	4 (.37%)
Renal Failure Chronic	4 (.37%)
Sepsis	4 (.37%)
Swelling	4 (.37%)
Thrombocytopenia	4 (.37%)
Ultrasound Scan Abnormal	4 (.37%)
Abdominal Discomfort	3 (.28%)
Agranulocytosis	3 (.28%)
Alpha 1 Foetoprotein Increased	3 (.28%)
Anaemia	3 (.28%)
Arthritis	3 (.28%)
Blood Alkaline Phosphatase Increase...	3 (.28%)
Blood Pressure Decreased	3 (.28%)
Breast Cancer	3 (.28%)
Cachexia	3 (.28%)
Cardiac Failure Congestive	3 (.28%)
Chills	3 (.28%)
Coronary Artery Stenosis	3 (.28%)
Decreased Appetite	3 (.28%)
Diaphragmatic Hernia	3 (.28%)
Drug Ineffective	3 (.28%)
Facial Palsy	3 (.28%)
Fatigue	3 (.28%)
Gastric Ulcer	3 (.28%)
Gastritis	3 (.28%)
Gastrooesophageal Reflux Disease	3 (.28%)
Granulocytopenia	3 (.28%)
Haematemesis	3 (.28%)
Haemolytic Anaemia	3 (.28%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Glucobay, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Glucobay is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Glucobay

What are the most common Glucobay adverse events reported to the FDA?

Gastrointestinal Signs	94 (8.66%)
Hepatobiliary	72 (6.64%)
Hepatic And Hepatobiliary	67 (6.18%)
Neurological	67 (6.18%)
Glucose Metabolism Disorders	64 (5.9%)
Gastrointestinal Stenosis And Obstr...	43 (3.96%)
Renal Disorders	37 (3.41%)
Gastrointestinal Motility And Defec...	29 (2.67%)
Urinary Tract Signs	26 (2.4%)
Hematology Investigations	24 (2.21%)
Infections - Pathogen Unspecified	22 (2.03%)
	Show More
Enzyme	21 (1.94%)
Coronary Artery	19 (1.75%)
Metabolic, Nutritional And Blood Ga...	19 (1.75%)
Epidermal And Dermal Conditions	16 (1.47%)
Cardiac Arrhythmias	15 (1.38%)
Gastrointestinal Hemorrhages	15 (1.38%)
Gastrointestinal Ulceration And Per...	15 (1.38%)
Respiratory	15 (1.38%)
Appetite And General Nutritional	14 (1.29%)
Therapeutic And Nontherapeutic Effe...	13 (1.2%)
Acid-base	10 (.92%)
Body Temperature Conditions	10 (.92%)
Electrolyte And Fluid Balance Condi...	10 (.92%)
Renal And Urinary Tract Investigati...	10 (.92%)
Skin Appendage Conditions	10 (.92%)
Cardiac Disorder Signs	9 (.83%)
Muscle	9 (.83%)
Physical Examination Topics	9 (.83%)
White Blood Cell	9 (.83%)
Bacterial Infectious	8 (.74%)
Cardiac And Vascular Investigations	8 (.74%)
Decreased And Nonspecific Blood Pre...	8 (.74%)
Gastrointestinal Inflammatory Condi...	8 (.74%)
Headaches	8 (.74%)
Nephropathies	7 (.65%)
Water, Electrolyte And Mineral	7 (.65%)
Central Nervous System Vascular	6 (.55%)
Medication Errors	6 (.55%)
Anemias Nonhemolytic And Marrow Dep...	5 (.46%)
Depressed Mood Disorders	5 (.46%)
Investigations, Imaging And Histopa...	5 (.46%)
Joint	5 (.46%)
Protein And Chemistry Analyses	5 (.46%)
Urolithiases	5 (.46%)
Encephalopathies	4 (.37%)
Heart Failures	4 (.37%)
Myocardial	4 (.37%)
Oral Soft Tissue Conditions	4 (.37%)
Peritoneal And Retroperitoneal Cond...	4 (.37%)
Platelet	4 (.37%)
Sexual Function And Fertility	4 (.37%)
Vascular	4 (.37%)
Anxiety Disorders	3 (.28%)
Breast Neoplasms Malignant And Unsp...	3 (.28%)
Cranial Nerve Disorders	3 (.28%)
Hemolyses And Related Conditions	3 (.28%)
Neurological, Special Senses And Ps...	3 (.28%)
Procedural And Device Related Injur...	3 (.28%)
Seizures	3 (.28%)
Soft Tissue Neoplasms Benign	3 (.28%)
Suicidal And Self-injurious Behavio...	3 (.28%)
Thoracic Disorders	3 (.28%)
Allergic Conditions	2 (.18%)
Bronchial Disorders	2 (.18%)
Cardiac Valve	2 (.18%)
Dental And Gingival Conditions	2 (.18%)
Exocrine Pancreas Conditions	2 (.18%)
Fatal Outcomes	2 (.18%)
Impulse Control	2 (.18%)
Increased Intracranial Pressure And...	2 (.18%)
Injuries	2 (.18%)
Lower Respiratory Tract Disorders	2 (.18%)
Mental Impairment	2 (.18%)
Metabolism	2 (.18%)
Pleural	2 (.18%)
Protein And Amino Acid Metabolism	2 (.18%)
Psychiatric And Behavioural Symptom...	2 (.18%)
Schizophrenia And Other Psychotic	2 (.18%)
Sleep Disturbances	2 (.18%)
Urethral Disorders	2 (.18%)
Vascular Hypertensive	2 (.18%)
Aneurysms And Artery Dissections	1 (.09%)
Angiedema And Urticaria	1 (.09%)
Benign Neoplasms Gastrointestinal	1 (.09%)
Bone And Joint Injuries	1 (.09%)
Changes In Physical Activity	1 (.09%)
Chemical Injury And Poisoning	1 (.09%)
Communication Disorders	1 (.09%)
Gastrointestinal Conditions	1 (.09%)
Gastrointestinal Neoplasms Benign	1 (.09%)
Gastrointestinal Neoplasms Malignan...	1 (.09%)
Hematological And Lymphoid Tissue T...	1 (.09%)
Immunology And Allergy	1 (.09%)
Lipid Metabolism	1 (.09%)
Lymphomas	1 (.09%)
Movement Disorders	1 (.09%)
Musculoskeletal And Connective Tiss...	1 (.09%)
Ocular Hemorrhages And Vascular	1 (.09%)
Ocular Neuromuscular	1 (.09%)
Peripheral Neuropathies	1 (.09%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Glucobay, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Glucobay is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.